Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
10.7%
% of IXJ's 113 holdings also in CANC
25.0%
% of CANC's 48 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.6% | 5.4% | 5.4% |
 |
NOVARTIS AG | 3.2% | 4.3% | 3.2% |
 |
ASTRAZENECA PLC | 3.0% | 4.2% | 3.0% |
|
MERCK & CO. INC. | 2.9% | 2.7% | 2.7% |
|
AMGEN INC | 2.2% | 2.8% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to CANC
|
UNITEDHEALTH GROUP INC | 6.0% |
|
JOHNSON & JOHNSON | 5.5% |
|
ELI LILLY & CO | 4.1% |
|
ABBOTT LABORATORIES | 3.3% |
|
ROCHE HOLDING LTD | 3.2% |
 |
NOVO NORDISK A/S-B | 2.9% |
|
ABBVIE INC | 2.6% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
|
BOSTON SCIENTIFIC CORP | 2.0% |
IXJ Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.7% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -5.1% |
|
BRIDGEBIO PHARMA, INC. | -4.5% |
|
NUVALENT, INC. CLASS A | -3.9% |
|
SUMMIT THERAPEUTICS INC | -3.9% |
|
EXELIXIS INC | -3.8% |
|
GENMAB A/S SPONSORED ADR | -3.4% |
 |
MERUS N.V. | -3.2% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.0% |
|
BLUEPRINT MEDICINES CORP. | -2.9% |